Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYCLOPHARM LIMITED Director's Dealing 2007

Jun 12, 2007

64741_rns_2007-06-12_df5252cc-639d-4733-b292-a0ee8c96dd1d.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity CYCLOPHARM LIMITED
IABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Henry George Townsing
Date of last notice 12/02/2007

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Normandy Nominees Limited (Nominee for
۰
Normandy Finance & Investments Asia
Limited)
Pilmora Pty Ltd (Director)
۰
Date of change 23/05/2007 to 7/06/2007
No. of securities held prior to change 13,384,933
Class Ordinary Shares
Number acquired Nil
Number disposed 129,500 1 and 291,844 2
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
\$43,932.50 1 and \$99,007.23 2

+ See chapter 19 for defined terms.

No. of securities held after change 12,963,589
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
On-market trade and off market trade * .
1. Parcel sold as on market trade.
2. No consideration for parcel. Estimated
value is based on the prevailing market price.

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notiliable interest of a director" should be disclosed in this part.

Detail of contract Nil
Nature of interest Nil
Name of registered holder
(if issued securities)
Nil
Date of change Nil
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Nil
Interest acquired Nil
Interest disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation.
Nil
Interest after change Nil

$+$ See chapter 19 for defined terms.